thermogenesis.com - THMO Total Company Value-to-Revenue Ratio

ThermoGenesis Holdings, Inc. (THMO) - corporate logo

The growth of regenerative medicine and the release of systems in the US support the dynamics of the EV/Sales ratio for ThermoGenesis (THMO). Revenue stability is ensured by a global network of laboratories and biobanks. However, liquidity shortages and slow time-to-market for products are creating financial pressure. The current value of shows the actual magnitude of the metric, while the chart in a sideways trend signals a risk of frozen investments.

ThermoGenesis Holdings Inc. (THMO) EV/Sales Multiple: for the period 07/04/2022 - 11/20/2026

Financial and market metric breakdowns for ThermoGenesis Holdings Inc. (THMO)

- share price and consensus valuation forecast:
Fundamental company valuation:THMO, thermogenesis.com
Flagship merchandise of ThermoGenesis Holdings, Inc.

EV/Sales is utilized to select assets with a high margin of safety, as it compares the total enterprise value to revenue, excluding the impact of debt load to identify actual market overvaluation. In the case of ThermoGenesis (THMO), the EV/Sales trend reflects the monetization efficiency of PXP systems and consumables, allowing investors to determine whether the current discount results from declining margins or represents an entry point.